EcoDrugPlus

Matrix Metallopeptidase 1

Ensembl ID : ENSSLUG00000013746
Gene Symbol: MMP1
3 Cross references
275 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSSLUG00000018215
Gene Symbol: MMP14
3 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 14b (Membrane-Inserted)

Ensembl ID : ENSSLUG00000009371
Gene Symbol: MMP14B
1 Cross references
196 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSSLUG00000021732
Gene Symbol: MMP2
3 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSSLUG00000006747
Gene Symbol: MMP9
3 Cross references
215 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSSLUG00000025759
Gene Symbol: MTOR
3 Cross references
216 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSSLUG00000011569
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:

Melanocortin Receptor 4-Like

Ensembl ID : ENSSLUG00000003786
Gene Symbol: LOC116040068
3 Cross references
89 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSSLUG00000004656
Gene Symbol: MTNR1A
3 Cross references
186 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSSLUG00000017275
Gene Symbol: MME
3 Cross references
231 Possible Orthologues:

Metabotropic Glutamate Receptor 2-Like

Ensembl ID : ENSSLUG00000014169
Gene Symbol: LOC116051232
3 Cross references
206 Possible Orthologues:

Metabotropic Glutamate Receptor 3-Like

Ensembl ID : ENSSLUG00000004985
Gene Symbol: LOC116045708
3 Cross references
215 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).